US prosecutors have accused nine senior Fifa officials of running a $150 million fraud through a “rampant, systemic and deep-rooted” corruption network to “acquire millions of...
The chief executive of British drug company GlaxoSmithKline (GSK), Sir Andrew Witty, has repeated that the firm has a “zero tolerance” policy when it comes corruption...
British companies that use bribes to win contracts could face tougher penalties, following new guidelines set out by the Sentencing Council. The guidelines recommend that judges...
Swiss and British pharmaceutical giants Novartis and GlaxoSmithKline (GSK) have swapped assets and agreed on creating a joint venture that will focus on consumer healthcare. The...
Pharmaceuticals giant GlaxoSmithKline (GSK) saw its drugs sales in China fall 61% between July and September. The decline follows a bribery investigation that began in July....
Ethical campaigners have criticised the Church in Wales for investing millions into four controversial pharmaceutical companies, prompting the Church to defend its ‘solid ethical investment policy’....
Pharmaceuticals giant GlaxoSmithKline (GSK) has announced that it is replacing its head of its operations in China Mark Reilly, amid allegations of corruption in the country....
Mike Appleby, a sustainable and responsible investment (SRI) analyst at Alliance Trust, explains how the investment house squares pharmaceuticals firm GlaxoSmithKline’s status as a viable sustainable...
Twenty-two years ago today, after the Bank of England’s Operation Sandstorm inquiry uncovered “widespread fraud and manipulation”, the Bank of Credit and Commerce International (BCCI) was...